Prion protein (PrP) is considered to associate with microtubule and its major component, tubulin. In the present study, octarepeat region of PrP (PrP51 -91) was expressed in prokaryotic-expressing system. Using GST pull-down assay and co-immunoprecipitation, the molecular interaction between PrP51-91 and tubulin was observed. Our data also demonstrated that PrP51 -91 could efficiently stimulate microtubule assembly in vitro, indicating a potential effect of PrP on microtubule dynamics. Moreover, PrP51-91 was confirmed to be able to antagonize Cu 21 -induced microtubule-disrupting activity in vivo, partially protecting against Cu 21 intoxication to culture cells and stabilize cellular microtubule structure. The association of the octarepeat region of PrP with tubulin may further provide insight into the biological function of PrP in the neurons.
Introduction
Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative disorders in humans and animals. These diseases are caused by conversion of an endogenous membrane glycoprotein (PrP C ) into a conformationally altered isoform (PrP Sc ) [1, 2] . Although a great deal has been learned about the PrP C -PrP Sc conversion event and the role of PrP Sc in the disease process, the normal function of PrP C remains enigmatic. A variety of functions have been proposed for PrP C , including roles in metal ion trafficking [3] , protection from oxidative stress and apoptosis [4, 5] , cell adhesion [6] , and transmembrane signaling [7] . Identifying the function of PrP C will provide important clues to understand the pathogenic mechanisms of prion diseases.
When considering PrP C 's function, most attention has been focused on its N-terminus, especially its five octarepeats. Residues 51 -91 of PrP contain an unusual glycine-rich repeat every eighth residue, and this sequence is termed as the octarepeat region (OR). Residues 60-91 consist of four octarepeat sequences (PHGGGWGQ) 4 and residues 51 -59 have a homologous sequence but lack the histidine residue (PQGGGTWGQ). The OR is among the most conserved parts of PrP in mammals [8] , and analogous sequences are present in other prion proteins, e.g. the seven hexameric repeats in chicken PrP [8] . Some human genetic prion diseases have been linked to the presence of additional octarepeat sequences [9] .
The OR of PrP can interact with several cellular proteins, e.g. tau, sGAG proteoglycan, tubulin, etc. [10, 11] , which are closely related to PrP C functions. Microtubules are essential and ubiquitous cytoskeletal elements composed of heterodimers of a-and b-tubulin, and play a central role in intracellular transport, metabolism and morphogenesis [12] . Some evidence demonstrate that PrP may associate with microtubule and its major component, tubulin [13] [14] [15] . Nieznanski et al. [16] have reported that the recombinant full-length PrP can inhibit microtubule assembly by inducing tubulin oligomerization. Hachiya et al. [17] have reported that the microtubule-associated intracellular localization requires at least the residues 1-91 of the N-terminal PrP C fragment. Several groups have also reported that the N-terminal fragment of PrP is essential for transportation of the plasma membrane and modulation of endocytosis along the microtubular track, and only prion protein possessing the N-terminal sequence (residues 23 -33 and 53-91, mouse PrP) can be actively transported [17, 18] . However, the biological mechanism of the interaction between PrP, especially the octarepeats, and tubulin remains unclear. Further studies of the association of PrP octarepeats with microtubular network may help to provide insight into the biological functions of PrP and to understand the possible pathogenesis of prion disease.
In the present study, we have investigated the association of PrP51-91 with tubulin, and evaluated the direct effect of PrP51-91 on microtubule dynamics. Our data showed that PrP51-91 was able to interact with tubulin and apparently induced the microtubule assembly in vitro. Moreover, PrP51-91 was confirmed to be able to efficiently antagonize Cu 2þ -induced inhibition of tubulin polymerization as well as Cu 2þ -induced cytotoxicity.
Materials and Methods
Plasmid construction and protein purification PrP51-91 and PrP91-231 (forward primer 5 0 -ggatccat gggtcaaggaggtggcacccac-3 0 with BamHI site underlined; reverse primer 5 0 -gaattctcacgatcctctcttgtaatagg-3 0 with EcoRI site underlined) were generated by PCR from fulllength wild-type hamster PRNP segment encoding amino acids 1-253 and inserted into a prokaryot ic-expressing vector pGEX-2T [19] . The recombinant prokaryotic protein tagged with GST was expressed and purified as described previously [19] . The concentration of tubulin purified from fresh hamster brains according to the procedure of microtubules preparation kit (Sigma, St. Louis, USA) was 5 mg/ml. Before experiments tubulin preparations were thawed from 2808C and cent rifuged at 20,000 g at 48C for 30 min. The obtained supernatants were used in subsequent tests.
Preparation of brain tissue homogenates
Normal hamsters' brain tissues were homogenized in nine volumes of lysis buffer (100 mM NaCl, 10 mM ethylenediaminetetraacetic acid, 0.5% Nonidet P-40, 0.5% Na deoxycholate, 10 mM Tris -HCl, pH 7.4). The hamsters' brain homogenates were centrifuged at 20,000 g for 30 min, and the supernatants were collected for subsequent experiments.
Pull-down assay
To identify whether the octarepeat region of PrP can interact with the native tubulin, 5 mM PrP51-91 tagged with GST was incubated with 0.2 ml of the supernatant of normal hamster brain homogenates at 48C for 4 h, while equal amount of GST protein and GST-PrP91-231 were used as control. Glutathione Sepharose 4B beads (10 ml) (GE Healthcare, Piscataway, USA) were added to the reaction solution and the mixture was incubated at 378C for 30 min with end-over-end mixing. After centrifugation at 500 g for 2 min, the supernatants were discarded and beads were washed with 500 ml of washing buffer (50 mM Tris -HCl, 300 mM NaCl, pH 8.0) for three times. The complexes were separated on 15% SDS-polyacrylamide gel and transferred to nitrocellulose filter blocked with 5% non-fat milk in PBST (135 mM NaCl, 1.3 mM KCl, 3.2 mM Na 2 HPO 4 , 0.5 mM KH 2 PO 4 , 0.05% Tween 20, pH 7.4). Tubulin reactive band was detected with anti-a-tubulin mAb (Santa Cruz Biotechnology, Santa Cruz, USA) (1:4000) as the primary antibody and then with HRP-conjugated anti-mouse IgG (Santa Cruz Biotechnology) (1:4000) as the secondary antibody. Finally, the bands were visualized using ECL western blotting detection reagents (Perkin-Elmer, Waltham, USA).
Co-immunoprecipitation
To see the interaction between the OR of PrP and the native tubulin, 5 mM GST-PrP51-91 was incubated with 0.2 ml of the supernatant of normal hamster brain homogenates at 48C for 4 h. After incubated with anti-GST mAb (Tiangen Biotechnology, Beijing, China) for 2 h, 10 ml of protein G Sepharose (Roche, Mannheim, Germany) was added and the mixture was incubated for 2 h. The Sepharose beads were precipitated at 500 g for 5 min and washed with 500 ml of washing buffer for three times. Equal amount of GST protein and GST-PrP91-231 were used as negative control. The bound complexes were separated by 15% SDS-PAGE and transferred to nitrocellulose membranes. The bound tubulin was detected with anti-a-tubulin mAb (1:4000) as the primary antibody and HRP-conjugated anti-mouse IgG (1:4000) as the secondary antibody. Protein bands were visualized using the ECL western blotting detection reagents.
Microtubule assembly assay
Microtubule assembly assay was performed in vitro using the purified tubulin of 3 mg/ml in the polymerization buffer containing 80 mM PIPES (N,N 0 -piperazine diethane sulfonic acid), pH 6.9, 0.5 mM MgCl 2 , 1 mM GTP (guanosine-5 0 -triphosphate), 5% glycerol. The turbidity of the solution was monitored at 340 nm continuously after mixing according to the protocols described previously [19] . The assay was performed for 30 min and the turbidity was measured every 5 min. The paclitaxel and GST were used as positive and negative controls.
Sedimentation experiments
Tubulin (3 mg/ml) was incubated with PrP51-91 and GST for 30 min, and the samples were subsequently centrifuged for 10 min at 14,000 g. The pellets were resuspended in a volume of deionized water equal to the volume of the supernatants and analyzed by 15% SDS-PAGE.
Fluorescent imaging of microtubule assembly
The samples containing tubulin (3 mg/ml) alone, tubulin with GST, Prp51-91, paclitaxel, Cu 2þ , and PrP51-91 with Cu 2þ were incubated with the polymerization buffer (80 mM PIPES, pH 6.9, 0.5 mM MgCl 2 , 1 mM GTP, 5% glycerol) at 378C for 30 min. To visualize assembled microtubules, tubulin and rhodamine-labeled tubulin (cytoskeleton) at the ratio of 7:1 were used in the polymerization buffer. Microtubules were fixed with 0.5% gluteraldehyde and visualized by fluorescence microscopy.
Cell viability determination
HeLa cells (Shanghai Institutes for Biological Sciences, Shanghai, China) were plated as normal in 96-well plates and maintained in DMEM containing 10% BSA. Various samples, including GST, PrP51-91, Cu 2þ , and Prp51-91 with Cu 2þ , were then applied directly to the wells according to different experiments. Viability was assessed by the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (Sigma) to a formazan product. Absorbance was measured at 492 nm using a spectrophotometer.
Confocal microscopy
To study the influence on the formation of microtubule in the cultured cells, the cells were incubated with GST, colchicine, PrP51-91, Cu 2þ , and PrP51-91 with Cu 2þ , for 24 h. After incubation, cells were extensively washed and then fixed in 4% paraformaldehyde. Triton X-100 (0.2%) was then added to allow antibody cellular penetration using anti-tubulin monoclonal antibody and Alexa488 (green) Fluor-conjugated anti-rabbit IgG (Invitrogen, Carlsbad, USA). Fluorescently stained cells were analyzed using a confocal laser scanning microscope (Leica, Wetzlar, Germany).
Statistical analysis
Differences were tested statistically by t-test. P , 0.05 was considered to indicate statistical significance.
Results
PrP51-91 forms complex with tubulin from hamster brain homogenate To address the molecular interactions of the OR of PrP with tubulin in brain tissues, GST-PrP51-91 and GST-PrP91-231 were employed to 0.2 ml of the supernatant of normal hamster brain homogenates in GST pull-down assay, while GST protein was used as control. , whereas no such band in the preparation with GST and GST-PrP91 -231 (lanes 3 and 4) was found. To confirm the observation in GST pull-down assay, hamster brain homogenates were mixed with GST-PrP51 -91 and GST-PrP91-231, followed by precipitation of anti-GST-mAb, while brain homogenates with GST were subjected to the same process in parallel. After blotting with anti-a-tubulin mAb, clear tubulin-specific signal was detected in the brain homogenate with PrP51-91 [ Fig. 1(B) , lane 2], but not in that with GST and GST-PrP91-231 (lanes 3 and 4). It confirms that the OR of PrP can form complex with tubulin from hamster brain homogenate.
PrP51-91 induces tubulin polymerization
To test whether the interaction between the OR of PrP and tubulin influences the tubulin polymerization in vitro, microtubule assembly assay was performed. PrP51-91 was mixed with tubulin in the polymerization buffer containing GTP and magnesium ions, while the preparations with paclitaxel and GST were used as positive and negative controls, respectively. Figure 2 revealed that the turbidity of the preparation of tubulin alone increased slowly with the incubation time, while addition of GST did not influence the curve. As a known tubulin-stabilizing agent, paclitaxel obviously increased the turbidity of the solution at each checkpoint (Fig. 2) . Interesting, the turbidity of the preparation remained almost unchanged when mixed with smaller amount of PrP51-91 (P ¼ 0.09) (molar ratio of PrP and tubulin: 1:8), whereas increased clearly when mixed with larger amounts of PrP51-91 (molar ratio of PrP and tubulin: 1:2, P , 0.01; 1:4, P , 0.05), showing an obvious dose-dependent manner (Fig. 2) . Meanwhile, addition of PrP51-91 at the highest concentration into the buffer without tubulin did not change the solution turbidity within 30 min (data not shown). It highlights that increasing turbidity of tubulin solution caused by PrP51-91 induces a similar way with that by paclitaxel.
To highlight the characteristics of microtubule in the solutions co-incubated with PrP51-91, a sedimentation test was performed. A relative higher amount of tubulin (3 mg/ml) that was believed for favoring microtubule formation [12, 18] and a relative lower speed centrifugation (14,000 g) that allowed sedimentation of only a proportion of microtubules polymerized were selected. The molar ratio of PrP and tubulin was fixed at 1:4. Following incubation and centrifugation, all input PrP51-91 still remained in the fraction of supernatant of the preparation containing PrP51 -91 alone [ Fig. 3(A) , lanes 1 and 2)], while a small portion of microtubule presented in pellet in the preparation of tubulin alone [ Fig. 3(A), lanes 3 and 4, and Fig. 3(B) ]. As expected, incubation with PrP51-91 showed portions of tubulin and PrP51-91 in pellet [ Fig. 3(A), lanes 5 and 6] . Incubations with GST did not change the distribution of tubulin, while the input GST presented only in the supernatant fraction [ Fig. 3(A) , lanes 7 and 8, and Fig. 3(B) ]. Analyses of the tubulin intensities in different fractions revealed that the ratio of tubulin in the pellet in the mixture of PrP51-91 and tubulin was obviously higher than those containing tubulin alone (P , 0.05) or tubulin with GST (P , 0.05) [ Fig. 3(B) ]. These results highly imply that both the rate and extent of tubulin polymerization were significantly enhanced by PrP51-91 in vitro.
PrP51-91 antagonizes Cu 21 -induced inhibition of microtubule assembly
Previous study showed that Cu 2þ inhibited tubulin polymerization [20] . To identify whether the OR of PrP can antagonize Cu 2þ -induced inhibition of tubulin polymerization, microtubule assembly assay was performed in the presence of PrP51-91, Cu 2þ , or Cu 2þ together with PrP51-91, respectively. As expected, the addition of PrP51-91 caused the apparent increase of turbidity of the preparation (P , 0.05). Contrarily, the turbidity of the preparation remarkably decreased in the presence of Cu 2þ . However, the decreasing turbidity caused by Cu 2þ could be blocked almost completely by PrP51-91 (P , 0.05) (Fig. 4) . It suggests that Cu 2þ , as a microtubule-disrupting agent, has an inhibitive effect on microtubule formation, whereas PrP51-91 efficiently protects against Cu 2þ -induced microtubule-disrupting activity.
PrP51-91 promotes microtubule formation by fluorescent imaging analysis
To get morphological evidence of the influences of PrP OR on microtubule formation in vitro, commercial rhodamine-labeled tubulin was applied to the tubulin polymerization experiments and the assembled microtubules were visualized by fluorescence microscopy. As shown in Fig. 5(A) , similar quantities of microtubule filaments and bundles were observed in the preparation of tubulin alone ( panel a) or with GST (panel b). Moreover, much tighter microtubule bundles were seen ( panel e). However, after the addition of Cu 2þ together with PrP51-91, the amount of microtubules increased obviously ( panel f ), suggesting that the extent of microtubule assembly was improved remarkably. The morphological data presented in Fig. 5(A) were further analyzed by Image-Pro Plus 6.0 software. It showed that the average intensity of the tubulin solution with PrP51-91 was higher than that with GST (P , 0.05). Meanwhile, the average intensity of the solution with Cu 2þ was remarkably low, showing statistical difference compared with that of Cu 2þ together with PrP51-91 (P , 0.05) [ Fig. 5(B) ]. These data confirmed again that the PrP51-91 can efficiently enhance tubulin polymerization and antagonize Cu 2þ -induced inhibition of tubulin polymerization, indicating a relatively strong influence of the OR on microtubule dynamics.
PrP51-91 protects against Cu 21 toxicity on the culture cells and stabilizes cellular microtubules
To identify the possible role of the PrP51-91 on the formation of cellular microtubule, the cultured HeLa cells were exposed to PrP51-91 for 24 h and the integrity of the cellular microtubule network was examined by immunofluorescent staining. Confocal microscopy showed that the cellular microtubule network in the cells receiving GST (Fig. 6, panel b) was quite similar to that in the mock cells ( panel a), whereas severe disruption of microtubule structure were observed in the cells treated with colchicine, a microtubule-disrupting agent (panel c). Obviously more condensed tubulin structures were detected in the cells receiving PrP51-91 ( panel d). Noticeably, in the presence of Cu 2þ , the cellular microtubule structures were significantly sparse ( panel e), albeit, when the cells were exposed to Cu 2þ and PrP51-91 together, the formation of microtubules was apparently improved ( panel f ). Analyses of the average intensities of morphological data presented in Fig. 6(A) with Image-Pro Plus 6.0 software revealed higher value in the cells with PrP51-91 than that with GST (P , 0.05), while intensity of the cells of Cu 2þ was significantly lower than that of Cu 2þ together with PrP51-91 (P , 0.05) [ Fig. 6(B) ]. It further suggests that PrP51-91 can efficiently protect against Cu 2þ -induced cytotoxicity. To address the possible effects of PrP51-91 on cell growth, HeLa cells were exposed to PrP51-91, Cu 2þ , Cu 2þ together with PrP51-91, respectively. MTT assay revealed that PrP51-91 or GST did not apparently increase the cell viability, while a marked reduction in cell activity was observed when 60 or 120 mM Cu 2þ was added (P , 0.05 and P , 0.05) [ Fig. 7(A) ]. Interestingly, PrP51-91 added together with Cu 2þ was able to protect partly against Cu 2þ intoxication [ Fig. 7(A) ]. Furthermore, we also assessed whether the adding order of PrP51-91 influences its antagonizing activity against Cu 2þ -induced cytotoxicity. Cu 2þ or PrP51-91 was firstly added for 12 h, and then PrP51-91 or Cu 2þ for another 12 h. MTT assays identified that addition of PrP51-91 prior to Cu 2þ significantly reduced the Cu 2þ -caused cytotoxicity (P , 0.05) [ Fig. 7(B) , column 5] that was comparable with that of addition of PrP51-91 and Cu 2þ together (column 3), whereas addition of PrP51-91 following Cu 2þ does not influence the Cu 2þ -caused cytotoxicity (P ¼ 0.789) (column 4) that was similar to that of Cu 2þ alone (column 2). Apparently, the adding order of PrP51-91 plays a vital role in antagonizing Cu 2þ intoxication, and the antagonizing activity of PrP51-91 should function prior to Cu 2þ -induced cytotoxicity.
Discussion
The N-terminus of PrP is highly flexible and lacks identifiable secondary structure, however, several biological activities, i.e. binding Cu 2þ and interacting with several neuron proteins, are confirmed to lie on this region, especially the OR, whose subsequent functions largely involve in Cu transport [3] , anti-apoptosis [5] , cell-cell interactions [21] , etc. Prion protein has been reported to undergo anterograde and retrograde motility in neurons [18] . The constructs lacking the amino acid residues 53-91 within mouse PrP losses its anterograde motility and congregates in an intracellular perinuclear compartment [18] . Our previous study and this study have provided the molecular evidence that the PrP octarepeats region was responsible for interacting with tubulin that is the major component of microtubule in vitro, thereby, playing an important role in the active transport of PrP along the microtubular track.
Microtubules are a major cytoskeletal constituent in all eukaryotes, which can be stabilized by structural MAPs (microtubule-associated proteins), such as tau [12] and other MAPs [22] . Microtubule networks are critical elements in a variety of fundamental functions, including intracellular scaffolding, cell division, secretory processes, regulatory of cellular motility, and transport [23] . It was reported that adenovirus-associated virus (AAV) underwent microtubule-dependent transport to the nucleus and cytoplasmic dynein significantly enhanced the binding of AAV capsid with microtubules in the process of transport [24] . The newly synthesized PrP C in neurons has to be sorted into a kind of vesicular transport machinery before being delivered to axons and terminals [25] .
Our previous data have demonstrated that in the context of whole protein (PrP23-231), PrP works as inhibitor for the formation of microtubule from tubulin in vitro [19, 26] . It has been already observed that the special region of PrP and the whole PrP protein behave distinct biological activities, i.e. PrP106-126 has clear cytotoxicity for neuronal cells, while the whole PrP protein shows benefit for the cultured cells [15] . PrP usually existed in the vesicles and is transported to the cell surface along with microtubule. Normally, the amount of PrP in the cytoplasm is very low and the cytosolic PrP can be immediately degraded by endoplasm proteasome. Therefore, PrP, as a whole protein, seems to have little chance to interact with tubulin. However, it has been repeatedly reported that the N-terminus peptide of PrP can protrude out of membrane of vesicles, so that it may have the chance to interact with tubulin, even with microtubule. One may speculate that PrP inside the vesicles might utilize its protruded N-terminal tail to contact with tubulin, inducing microtubule formation and subsequently facilitating the active transport of PrP along the microtubular track. The fCJD-related insertions within octarepeats show stronger activities to bind tubulin; however, what they induce is the aggregation of tubulin rather than the formation of microtubule [19] . Hence, the transportation process may be hindered. In fact, PrP carrying nine extra octarepeats (PG14) are significantly delayed in their transit along the secretory pathway [27] , which may result in the accumulation of the mutated PrP in the cells and subsequently cause cytopathic effectiveness.
Trace elements (e.g. Cu 2þ ) are essential for functions of many specific proteins, such as metalloenzymes, oxygen transporters and redox activities [28] . As their concentration exceeds the physiological level, however, their effects on cells become deleterious and toxic that causes cellular pathological effects [27] . Cu 2þ has shown inhibitive effects on microtubule assembly [29] . Our data have confirmed this phenomenon that Cu 2þ prohibits both tubulin polymerizations at the level of protein and microtubule formations in the cultured cells. The octapeptide repeat region binds divalent metal ions via the repeated histidine residues [3] . Many PrP functions are associated with its Cu 2þ binding. PrP has also been proposed to function as a Cu-transport protein [3] . The presence of Cu 2þ can confer different strains of prion disease with different protease resistance properties and can enhance reversibility of scrapie inactivation [30] . The endocytosis of PrP C is enhanced by its binding with Cu and zinc [31] . Through binding with divalent metal ions, PrP involves in the metabolism and transportation of these metal ions.
Moreover, we have firstly identified that the octarepeats region of PrP can efficiently antagonize Cu 2þ -induced inhibition of tubulin polymerization in vitro, as well as significantly stabilize cellular microtubule structure and partly protect against Cu 2þ -induced cytotoxicity. Presence of Cu 2þ in the culture medium causes obviously low cell viability. Although the reasons of Cu 2þ -related cell death may be multiplicate, great inhibition of the formation of microtubule sets up reasonable linkage between two phenomena. Disrupting tubulin and microtubule dynamics by some chemicals leads to metaphase arrest in the dividing cells and induction of apoptosis [32] . As a cell surface protein, wildtype PrP shows clearly cell protective activities in the context of whole protein, while the mutations within octarepeats usually display cytotoxicities [10, 19] . The data in this study provide reliable evidence that PrP protective function lies on its octarepeats, which is likely associated with the enhancement of the formation and stabilization of microtubule. Additionally, our data have identified that the reversion of Cu 2þ -induced cytotoxicity by PrP51-91 happens in the condition of employment of PrP51-91 and Cu 2þ simultaneously or application of PrP51-91 firstly. However, PrP octarepeats show almost no protective effect on the cells pre-treated with Cu 2þ . It highlights that the antagonizing activity of PrP51-91 may associate with the binding of Cu. Since the tubulin cytoskeleton is a key component of the maintenance and stability of the nervous tissue, the protective function of the octarepeats region described here may further provide insight into the unresolved physiological function of PrP in the neurons.
